Skip to content

Erasca, Inc. ERAS Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Amgen logo
AmgenAMGN
$4.11B+26.2%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$59.83M+87.5%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$12.49M+60.6%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$18.35M+19.4%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$11.84M-46.1%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s prepaid & other current?
Erasca, Inc. (ERAS) reported prepaid & other current of $10M in Q1 2026.
How has Erasca, Inc.'s prepaid & other current changed year-over-year?
Erasca, Inc.'s prepaid & other current decreased by 0.4% year-over-year, from $10.03M to $10M.
What is the long-term trend for Erasca, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Erasca, Inc.'s prepaid & other current has grown at a 51.1% compound annual growth rate (CAGR), from $1.29M to $10.16M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.